Revagenix - Crunchbase Company Profile & Funding

Q: Who invested in Revagenix?

Revagenix has 3 investors including Tenmile And Novo Holdings.

Q: When was the last funding round for Revagenix?

Revagenix closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Revagenix raised to date?

Revagenix has raised obfuscated.

Overview

Revagenix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Revagenix

CB Rank

93902

Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.

Founded

obfuscation

Private

Series B

San Mateo, California, United States

1-10

www.revagenix.com

Biotechnology

Pharmaceutical

Service Industry

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Andrew McCandlish: COO
Ryan Cirz: CEO and Acting CSO

Details

Legal Name

Revagenix, Inc.

Operating Status

Active

Company Type

For Profit

Phone Number

(650) 228-3244

Predictions & Insights

Growth Insight

See this Growth Insight

Revagenix is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Proprietary Antibiotic Programs

A pipeline of antibiotic candidates in late preclinical development aimed at treating drug-resistant infections.

Research & Development

Revagenix is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B
obfuscated obfuscation	Series B - Revagenix	3	obfuscated obfuscation	Novo Holdings, Tenmile	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Tenmile	Yes	Series B - Revagenix	Michael Lamprecht, Steve Burnell
Tenmile	Yes	Series B - Revagenix	Michael Lamprecht, Steve Burnell
Tenmile	Yes	Series B - Revagenix	Michael Lamprecht, Steve Burnell
Tenmile	Yes	Series B - Revagenix	Michael Lamprecht, Steve Burnell
Tenmile	Yes	Series B - Revagenix	Michael Lamprecht, Steve Burnell